Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests

Excess assemblage value tin rise the hazard of definite cancers, starring researchers to wonderment whether blockbuster drugs similar Wegovy, Ozempic and Zepbound could play a relation successful cancer prevention.

Now, a survey of 170,000 diligent records suggests there's a somewhat little hazard of obesity-related cancers successful U.S. adults with diabetes who took these popular medications compared to those who took different people of diabetes cause not associated with value loss.

This benignant of survey can't beryllium origin and effect, but the findings hint astatine a transportation worthy exploring. More than a twelve cancers are associated with obesity.

“This is simply a telephone to scientists and objective investigators to bash much enactment successful this country to truly beryllium oregon disprove this,” said Dr. Ernest Hawk of MD Anderson Cancer Center successful Houston, who was not progressive successful the study.

The findings were released Thursday by the American Society of Clinical Oncology and volition beryllium discussed astatine its yearly gathering successful Chicago. The study, funded by the National Institutes of Health, was led by Lucas Mavromatis, a aesculapian pupil astatine New York University’s Grossman School of Medicine.

“Chronic illness and chronic illness prevention are immoderate of my passions,” said Mavromatis, a erstwhile probe chap with an NIH grooming program.

GLP-1 receptor agonists are injections utilized to dainty diabetes, and immoderate are besides approved to dainty obesity. They enactment by mimicking hormones successful the gut and the encephalon to modulate appetite and feelings of fullness. They don't enactment for everyone and tin nutrient broadside effects that see nausea and tummy pain.

In the study, researchers analyzed information from 43 U.S. wellness systems to comparison 2 groups: radical with obesity and diabetes who took GLP-1 drugs and different radical with the aforesaid conditions who took diabetes drugs similar sitagliptin. The 2 groups were adjacent successful size and matched for different characteristics.

After 4 years, those who took GLP-1 drugs had a 7% little hazard of processing an obesity-related crab and an 8% little hazard of decease from immoderate origin compared to those who took the different benignant of diabetes drug. There were 2,501 caller cases of obesity-related crab successful the GLP-1 radical compared to 2,671 cases successful the different group.

The effect was evident successful women, but not statistically important successful men. The survey couldn't explicate that difference, but Mavromatis noted that differences successful humor cause concentration, value loss, metabolism oregon hormones could beryllium astatine play.

___

The Associated Press Health and Science Department receives enactment from the Howard Hughes Medical Institute’s Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely liable for each content.

Copyright 2025 The Associated Press. All rights reserved. This worldly whitethorn not beryllium published, broadcast, rewritten oregon redistributed without permission.